A REVIEW ON CURRENT ADVANCES IN NANOTECHNOLOGY APPROACHES FOR THE EFFECTIVE DELIVERY OF ANTI-CANCER DRUGS
Nanotechnology has achieved the status as one of the vital research endeavors of 21stcentury, which may be called as â€œNano-Centuryâ€ with nanotechnology making its presence felt in different spheres of lives. Nanotechnology may be defined as the creation of materials, drugs and devices that are used to manipulate matter of size in the range of 1-100nm. Nanotechnology has found its applications in many fields related to medicine including novel drug delivery systems. Many different types of nanosystems have been utilized in diagnostics and therapeutics of various diseases. To subside the disadvantages of conventional cancer therapeutics, nanotechnology has been given considerable attention. The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the cancer. These have been applied to improve drug delivery and to overcome some of the problems of drug delivery in cancer. Current nanotechnology platforms for cancer therapeutics encompass a vast array of nanomaterials and nanodevices. This review will focus on seven of the most prominent and most widely studied: Â polymeric nanoparticles, nanoshells, carbon nanotubes, dendrimers, quantum dots, superparamagnetic nanoparticles, and liposomes. All of these nanotechnology platforms can be multifunctional, so they are frequently touted as â€œsmartâ€ or â€œintelligent.â€ It is concluded how nanotechnology can help solve one of the most challenging and longstanding problems in medicine, which is how to eliminate cancer without harming normal body tissue.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).